1. Home
  2. IRWD vs DH Comparison

IRWD vs DH Comparison

Compare IRWD & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • DH
  • Stock Information
  • Founded
  • IRWD 1998
  • DH 2011
  • Country
  • IRWD United States
  • DH United States
  • Employees
  • IRWD N/A
  • DH N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • DH Computer Software: Prepackaged Software
  • Sector
  • IRWD Health Care
  • DH Technology
  • Exchange
  • IRWD Nasdaq
  • DH Nasdaq
  • Market Cap
  • IRWD 251.8M
  • DH 298.7M
  • IPO Year
  • IRWD 2010
  • DH 2021
  • Fundamental
  • Price
  • IRWD $1.76
  • DH $3.00
  • Analyst Decision
  • IRWD Buy
  • DH Hold
  • Analyst Count
  • IRWD 5
  • DH 5
  • Target Price
  • IRWD $4.94
  • DH $4.35
  • AVG Volume (30 Days)
  • IRWD 1.2M
  • DH 304.7K
  • Earning Date
  • IRWD 11-04-2025
  • DH 11-06-2025
  • Dividend Yield
  • IRWD N/A
  • DH N/A
  • EPS Growth
  • IRWD N/A
  • DH N/A
  • EPS
  • IRWD N/A
  • DH N/A
  • Revenue
  • IRWD $308,519,000.00
  • DH $244,926,000.00
  • Revenue This Year
  • IRWD N/A
  • DH N/A
  • Revenue Next Year
  • IRWD N/A
  • DH $0.68
  • P/E Ratio
  • IRWD N/A
  • DH N/A
  • Revenue Growth
  • IRWD N/A
  • DH N/A
  • 52 Week Low
  • IRWD $0.53
  • DH $2.15
  • 52 Week High
  • IRWD $5.13
  • DH $5.68
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 63.49
  • DH 36.60
  • Support Level
  • IRWD $1.43
  • DH $2.87
  • Resistance Level
  • IRWD $1.71
  • DH $3.01
  • Average True Range (ATR)
  • IRWD 0.13
  • DH 0.14
  • MACD
  • IRWD 0.01
  • DH 0.02
  • Stochastic Oscillator
  • IRWD 66.04
  • DH 38.30

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: